Transmembrane AMPA receptor regulatory proteins expression during the development of absence seizures in the Genetic Absence Epilepsy Rats from Strasbourg

Pablo M. Casillas‐Espinosa,Runxuan Lin,Rui Li,Kim L. Powell,Terence J. O'Brien
DOI: https://doi.org/10.1111/epi.17837
IF: 6.74
2023-12-02
Epilepsia
Abstract:The transmembrane AMPA receptor regulatory proteins(TARPs), γ2(stargazin), γ3, γ4, γ5, γ7 and γ8, are a family of proteins that regulate AMPAR trafficking, expression, and biophysical properties that could have a role in the development of absence seizures. Here, we evaluated the expression of TARPs and AMPA receptors across the development of epilepsy in the Genetic Absence Epilepsy Rats from Strasbourg (GAERS) model of idiopathic generalised epilepsy (IGE) with absence seizures. Pre‐epileptic (7‐day‐old), early epileptic (6‐week‐old) and chronically epileptic (16‐week‐old) GAERS, and age‐matched male non‐epileptic control (NEC) were used. EEG recordings were acquired from the 6‐ and 16‐week‐old animals to quantify seizure expression. Somatosensory cortex (SCx) and whole thalamus were collected from all the animals to evaluate TARPs and AMPA receptors mRNA expression. Analysis of the EEG demonstrated a gradual increase in the number and duration of seizures across GAERS development. mRNA expression of the TARPs γ2, γ3, γ4, γ5 and γ8 in the SCx, γ4 and γ5 in the thalamus, increased as the seizures start and progress in the GAERS compared to NEC. There is a temporal association between increased TARP expression and seizures in GAERS, highlighting TARPs as potential targets for developing novel treatments for IGE with absence seizures. This article is protected by copyright. All rights reserved.
clinical neurology
What problem does this paper attempt to address?